As China has become a critical player in pharmaceutical innovation,

The Galien Foundation has entrusted the R&D-Based Pharmaceutical Association Committee (RDPAC) to launch the Prix Galien China Awards. The award ceremony will take place in Beijing, aligned with the International Pharmaceutical Innovation Forum (IPIF). The combination of the IPIF and the Prix Galien is unique, bringing together leading academics, industry researchers, health system administrators, political leaders, patient NGOs, and media around a common theme of healthcare and innovation. Awards are made in three categories: Innovative Product, Research, and Digital Innovation for Impact.

The application and nomination process for the inaugural Prix Galien China opened September 2018. Applicants may download the application form and send the submission to

Submission deadline is December 15, 2018.


Christine Hu:

For acomprehensivelist ofpast winnersvisit ourHall of Fame

Committee members:

  • Lieping CHEN, Immunologist & Oncologist, Yale University
  • Joseph GOLDSTEIN, Professor & Director, European Center of Pharmaceutical Medicine, University of Basel
  • Chen WANG, Vice President, Chinese Academy of Engineering; President, Chinese Academy of Medical Science & Peking Union Medical College
  • Susan DESMOND-HELLMANN, CEO, Bill & Melinda Gates Foundation
  • Yigong SHI, Dean, School of Life Sciences, Tsinghua University
  • Yi RAO, Neurobiologist & Former Dean, School of Life Science, Peking University
More about PG China

From national and world leaders to shining lights within the pharmaceutical industries, many have offered praise for the Prix Galien.